Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  metoclopramide hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-15 of 15 for your search:
Start Over
Drugs to Reduce the Side Effects of Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 90/95, SWS-SAKK-90/95, EU-97035, CDR0000066073, NCT00003213
Phase III Adjuvant Chemotherapy with Intravesical ADR Alone and in Combination with Systemic cis-Platinum and 5-FU in Adult Patients with Superficial Bladder Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSUCTC-8417, NCI-V85-0102
Phase III, Double-Blind, Multiple Dose Study of Intranasal Metoclopramide vs Placebo in Cancer Patients Treated with Emetogenic Chemotherapy (Summary Last Modified 02/92)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-91118, NCI-V91-0197
Randomized Double-Blind Comparison of Metoclopramide vs Tetrahydrocannabinol to Control CACP-Induced Vomiting
Phase: Phase II, Phase I
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-8127
Phase I/II Regional Chemotherapy with CACP/DCM for Advanced Head and Neck Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAB-154, NCI-T83-1229D, T83-1229
Phase II Randomized Study of High-Dose Metoclopramide for Doxorubicin and Cyclophosphamide-Induced Nausea and Vomiting in Patients With Soft Tisuue Sarcoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-83-C-72, NCI-T83-1453
Phase II Induction Chemotherapy with High-Dose CACP in Hypertonic Saline for Patients with Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8487R, NCI-T84-0410D, T84-0410
Phase II Study of Antiemesis with MDM (Midazolam/Dexamethasone/Metoclopramide) in Patients Receiving High-Dose Cisplatin (Summary Last Modified 07/90)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-88143, NCI-V89-0039
Trial of Antiemetic Therapy with MDM (Midazolam/Dexamethasone/Metoclopramide) in Patients Receiving Cisplatin for Malignancies (Summary Last Modified 08/90)
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-89098, NCI-V89-0193
Evaluation of MDLO (Metoclopramide/Dexamethasone/Lorazepam/Ondansetron) for the Prevention of Acute Vomiting In Cancer Patients Receiving High-Dose Cisplatin (Summary Last Modified 11/92)
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-91072, NCI-V91-0180
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Si094/2009, NCT01093690
Start Over